跳至主要内容
临床试验/NL-OMON54579
NL-OMON54579招募中不适用

ational study of inherited platelet function disorders in the Netherlands - Trombocytopathy in the Netherlands / TI

niversitair Medisch Centrum Utrecht0 个研究点目标入组 600 人开始时间: 待定最近更新:
适应症

试验速览

阶段
不适用
状态
招募中
发起方
入组人数
600

研究概览

简要总结

暂无简介。

研究设计

研究类型
Observational

入排标准

年龄范围
0 至 99(—)

入选标准

  • (Suspected) PFD defined according to the following criteria:
  • Congenital or familial thrombocytopenia
  • Chronic thrombocytopenia (>1 year) without proven or suspected acquired cause
  • PFD with proven molecular diagnosis.
  • Abnormal LTA for at least one of the agonists and/or abnormal ATP/ADP ratio
  • (storage pool test)
  • History of bleeding diathesis very suspect of a primary hemostasis function
  • defect with or without prolonged Platelet Function Analyser closure time.
  • Inclusion criteria of control group of VWD patients for bruising pattern
  • Patients younger than 18 years old with Von Willebrand*s disease type 1 or type
  • 2 that visit the VCK regularly.

排除标准

  • - Inability to give informed consent or inability of the parents to give
  • informed consent in patients < 16 years of age.
  • - Bleeding diathesis due to an acquired PFD
  • - Bleeding diathesis due to moderate or severe von Willebrand disease (VWF
  • risto < 30%)
  • - Bleeding diathesis due to hemophilia or other disorders of secondary
  • hemostasis or fibrinolysis
  • - Current use of antiplatelet therapy

研究者

发起方
niversitair Medisch Centrum Utrecht

相似试验